Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease

被引：0
|
作者：
Sunil Taneja
Ajay Duseja
Arka De
Manu Mehta
Raja Ramachandran
Vivek Kumar
Harbir Singh Kohli
Krishan Lal Gupta
Radha Krishan Dhiman
Yogesh Chawla
机构：
[1] Postgraduate Institute of Medical Education and Research,Department of Hepatology
[2] Postgraduate Institute of Medical Education and Research,Department of Nephrology
来源：
Digestive Diseases and Sciences | 2018年 / 63卷
关键词：
Chronic hepatitis C; Sofosbuvir; Daclatasvir; Chronic kidney disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1334 / 1340
页数：6
相关论文
共 50 条
  • [31] Hepatitis C virus infection in patients with end-stage renal disease
    Wigneswaran, John
    Van Wyck, David
    Pegues, David
    Gholam, Pierre
    Nissenson, Allen R.
    HEMODIALYSIS INTERNATIONAL, 2018, 22 (03) : 297 - 307
  • [32] FULL-DOSE PEGINTERFERON ALPHA-2A AND LOW-DOSE RIBAVIRIN TREATMENT OF GENOTYPE 1 AND 4 CHRONIC HEPATITIS C PATIENTS WITH END-STAGE RENAL DISEASE
    Agha, Adnan
    Ali, Mamdouh M. Abdulhadi
    Saudi, Dib
    Furnari, Manuele
    Savarino, Vincenzo
    Giannini, Edoardo G.
    HEPATOLOGY, 2011, 54 : 871A - 871A
  • [33] Full-Dose Peginterferon Alfa-2a and Low-Dose Ribavirin Treatment of Genotypes 1 and 4 Chronic Hepatitis C Patients With End-Stage Renal Disease
    Abdulhadi-Ali, Mamdouh M.
    Alsaudi, Dib
    Agha, Adnan
    Ibraheem-Alqahtani, Nasser
    Furnari, Manuele
    Savarino, Vincenzo
    Giannini, Edoardo G.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (11) : 1004 - 1004
  • [34] Thrombocytopenia in end-stage renal disease and chronic viral hepatitis B or C
    Orasan, Olga Hilda
    Urian, Laura
    Ciulei, George
    Breaban, Iulia
    Stefan, Andreea Maria
    Secara, Sorina Cezara
    Taut, Adela-Sitar
    Sarlea, Simina Tarmure
    Negrean, Vasile
    Sampelean, Dorel
    Patiu, Ioan Mihai
    Orasan, Remus Aurel
    Cozma, Angela
    JOURNAL OF MIND AND MEDICAL SCIENCES, 2018, 5 (02): : 236 - 243
  • [35] Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review
    Aguirre Valadez, Jonathan
    Garcia Juarez, Gnacio
    Rincon Pedrero, Rodolfo
    Torre, Aldo
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 329 - 338
  • [36] Treatment of chronic hepatitis C in patients with end-stage renal disease and hemophilia the Singapore experience
    Chow, WC
    Tien, SL
    Tan, CK
    Lui, HF
    Vathsala, A
    Ng, HS
    INTERVIROLOGY, 2005, 49 (1-2) : 107 - 111
  • [37] Pharmacokinetics of elbasvir and grazoprevir in subjects with end-stage renal disease or severe renal impairment
    Luzelena Caro
    Larissa Wenning
    Hwa-Ping Feng
    Zifang Guo
    Lihong Du
    Pratik Bhagunde
    Christine Fandozzi
    Deborah Panebianco
    William L. Marshall
    Joan R. Butterton
    Marian Iwamoto
    Wendy W. Yeh
    European Journal of Clinical Pharmacology, 2019, 75 : 665 - 675
  • [38] Pharmacokinetics of elbasvir and grazoprevir in subjects with end-stage renal disease or severe renal impairment
    Caro, Luzelena
    Wenning, Larissa
    Feng, Hwa-Ping
    Guo, Zifang
    Du, Lihong
    Bhagunde, Pratik
    Fandozzi, Christine
    Panebianco, Deborah
    Marshall, William L.
    Butterton, Joan R.
    Iwamoto, Marian
    Yeh, Wendy W.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (05) : 665 - 675
  • [39] The impact of chronic Hepatitis B in end-stage renal disease
    Bechly, K. A.
    Gane, E.
    Manley, P.
    Dickson, G.
    Pilmore, H.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A326 - A326
  • [40] Is hepatitis C more aggressive in renal transplant patients than in patients with end-stage renal disease?
    Perez, Renata M.
    Ferreira, Adalgisa S. P.
    Medina-Pestana, Jose O.
    Cendoroglo-Neto, Miguel
    Lanzoni, Valeria P.
    Silva, Antonio Eduardo B.
    Ferraz, Maria Lucia G.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (05) : 444 - 448
12345